Building a Renal Denervation Program-Highlight's of SCAI's Expert Consensus Roundtable on RDN for HTN Patients

Video Transcription

Video Summary

The video transcript discusses highlights from Sky's Expert Consensus Roundtable on renal denervation for hypertensive patients. The roundtable consisted of subject matter experts from Sky and the National Kidney Foundation discussing various topics related to renal denervation, including blood pressure control, risk evaluation, treatment pathways, and ideal patients for the procedure. The group acknowledged a new metric called TTR (time and target range) as a potential endpoint in future studies. They also emphasized the importance of good access to care, interdisciplinary collaboration, and simplified hypertension regimens for patients. The transcript mentions the device providing stabilization of blood pressure, potential medication decrease, and improvements in quality of life. It suggests that patients with elevated cardiovascular risk should be prioritized for the procedure. The transcript also touches on the terminology used, distinguishing between resistant hypertension and uncontrolled hypertension. Safety and effectiveness are briefly discussed, highlighting the low complication rates and constant reduction in blood pressure with treatment. The ideal patient initially would be those with uncontrolled hypertension despite guideline-directed medical therapy (GDMT). The transcript suggests the importance of confirming hypertension through alternative means of blood pressure monitoring and the significance of shared decision-making between patients and healthcare providers. The transcript mentions an ongoing paper focusing on the implementation of renal denervation into clinical practice, including patient selection, optimal techniques, training, and organizational recommendations. It encourages viewers to review and provide comments on the document, which recently went live for public review. The video features an unidentified speaker.

Asset Subtitle

Rajesh Swaminathan, MD, FSCAI

Keywords

renal denervation

hypertensive patients

blood pressure control

TTR

risk evaluation